Who SHOULD get the vaccine:
The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) recommend that the following people receive hepatitis B vaccination:
The hepatitis B vaccine is safe and effective. Studies indicate that immunity persists for at least 30 years among healthy people who initiate hepatitis B vaccination at less than 6 months of age.
Who should NOT get the vaccine:
If you have insurance:
If you are uninsured or underinsured:
Locating Vaccine Clinics:
If you are unsure of your hepatitis B vaccination status, you can request a copy of your records.
To request your record:
If your vaccines are not listed, ask your doctor, pharmacist, or vaccine provider for a copy of your vaccine records. You can also ask them to add your vaccines to the California Immunization Registry (CAIR).
Other tips to find your records:
Confirmed or suspected hepatitis B cases are to be reported within seven (7) calendar days from identification, by electronic transmission (including fax or email) or telephone to Los Angeles County Public Health Department's Communicable Disease Reporting System (CDRS) per Title 17, California Code of Regulations, Section 2500. When reporting, specify if this is an acute, chronic, or perinatal case, and whether or not the individual is pregnant.
The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) recommend routine hepatitis B vaccination for infants, children, adolescents, and adults.
Infants and Children
The AAFP recommends a dose of single antigen hepatitis B vaccine (ENGERIX-B [GlaxoSmithKline] or RECOMBIVAX HB® [Merck]) within 24 hours of birth for all infants born to people who are HBsAg negative. Additional doses should be administered at ages:
The 3rd and final dose should be administered at age 6 months (24 weeks).
A 4th dose is permitted at age 6 months when using combination vaccines after the birth dose, such as PEDIARIX (GlaxoSmithKline) or VAXELIS® (Sanofi Pasteur).
Vaccine recommendations for infants born to people who are HBsAg positive or have unknown hepatitis B status at time of delivery can be found here.
All children and adolescents aged <18 years not previously vaccinated require 3 doses at 0, 1, and 6 months.
Adolescents ages 11-15 years may receive a 2-dose series of RECOMBIVAX HB® with at least 4 months between doses. The 2-dose series should be completed prior to the 16th birthday.
Adults
CDC recommends the following adults receive hepatitis B vaccination:
Guidance for PREHEVBRIO
The PREHEVBRIO vaccine was voluntarily recalled by VBI Vaccines in late 2024 due to the company’s termination of operations.
| Hepatitis B-Containing Vaccines and Brands | Number of Doses | Age for Primary Series | Dose & Route | |||
|---|---|---|---|---|---|---|
| Dose 1 | Dose 2 | Dose 3 | Dose 4 | |||
| ENGERIX-B (HepB) GlaxoSmithKline (GSK) |
3 | Birth | 1 mo | 6 mos | N/A | 0.5 mL IM |
| 3 | ≥20 yrs | 1 mo after Dose 1 | 16 wks-6 mos after Dose 1 | N/A | 0.5 mL IM | |
| 4 | Adults on hemodialysis | 1 mo after Dose 1 | 2 mos after Dose 1 | 6 mos after Dose 1 | 2 mL IM or two (2) 1 mL doses | |
| RECOMBIVAX HB® (HepB) Merck |
3 | Birth | 1 mo | 6 mos | N/A | 0.5 mL IM |
| 2 | 11-15 yrs | 4-6 mos after Dose 1 | N/A | N/A |
1 mL IM | |
| 3 | 11-15 yrs | 1 mo after Dose 1 | 6 mos after Dose 1 | N/A | 1 mL IM | |
| 3 | Birth | 1 mo | 6 mos | N/A | 1 mL IM | |
| HEPLISAV-B® (HepB) Merck |
2 |
Birth | 1 mo | N/A | N/A | 0.5 mL IM |
| PEDIARIX (DTaP-HepB-IPV) GlaxoSmithKline (GSK) |
3 |
2 mos | 4 mos | 6 mos | N/A | 0.5 mL IM |
| VAXELIS® (DTaP-IPV-Hib-HepB)* MSP Vaccine Company |
3 | 2 mos | 4 mos | 24 wks-6 mos** | N/A | 0.5 mL IM |
| TWINRIX (HepA-HepB) GlaxoSmithKline (GSK) |
3 | ≥18 yrs | 1 mo after Dose 1 | 6 mos after Dose 1 | N/A | 1 mL IM |
| 4 | ≥18 yrs | 7 days after Dose 1 | 21-30 days after Dose 1 | 12 mos after Dose 1 | 1 mL IM | |
*Preferred for American Indian and Alaska Native infants based on the Haemophilus influenzae type b (Hib) component.
** The recommended minimum age for dose 3 of VAXELIS® is 24 weeks, the minimum age for completion of the hepatitis B vaccine series.
Administration Data: California healthcare providers are required to report data on all valid immunizations that they administer to their patients into the California Immunization Registry (CAIR) within 2 weeks of administration per AB 1797.
Administration Errors: Healthcare providers are strongly recommended to report all vaccine administration errors to the Institute for Safe Medication Practices.
Adverse Events: Healthcare providers are required to report any adverse event on the reportable events list to the Vaccine Adverse Event Reporting System (VAERS) per HR 5546.
Storage and Handling: For general recommendations and guidance access the Vaccine Storage and Handling Job Aids.